Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2022 Earnings

Operator: Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode.

Related Keywords

Brazil , China , United States , Chinese , America , American , Steve Wargacki , Jason Butler , Andreas Argyrides , Thomas Flaten , Gary Nachman , Ernie Toth , Dan Barber , Rd Steve Wargacki , Ram Selvaraju , Ken Truitt , James Malloy , Francois Brisebois , Bennett Watson , Ken Marshall , Alliance Global Partners , Biodelivery Sciences International , Nasdaq , American Academy Of Allergy , Aquestive Therapeutics Inc , Exchange Commission , Trademark Office , Assertio Holdings , Office Of Orphan Products Development , Otter Pharmaceuticals , Aquestive Therapeutics , Call Transcript March , Aquestive Therapeutics Fourth Quarter , Full Year , Chief Executive Officer , Chief Financial Officer , Vice President , Chief Commercial , Risk Factors , Epinephrine Sublingual Film , American Academy , Scientific Advisory Board , South America , Orphan Products Development , Preview Division , Buccal Film , Chief Commercial Officer , Hypera Brazil , Epinephrine Prodrug , Alliance Global ,